Ficci: Some drugs may not last beyond Feb because of virus crisis - (The Economic Times via NewsPoints Desk)

  • According to an assessment on industry feedback conducted by the lobby group FICCI, production of several commonly used medicines such as paracetamol, ibuprofen, some antibiotics and diabetes drugs may be adversely hit if the supply disruption caused by the COVID-19 outbreak in China lasts beyond two months, reported The Economic Times.

  • In several cases, Indian drugmakers have raw material stocks of two to three months and so do not see any immediate problem, but this could change if the problem persists, the assessment said.

  • "Also, if the shutdown extends beyond February, then there may be some rise in prices of pharmaceutical products made in India," the report further noted.

  • India depends on China for around 70% of its bulk drugs and drug intermediates, according to industry estimates, but in certain segments, such as penicillins and their derivatives, China accounts for over 90% of India's import of the ingredient, the study said.

  • Meanwhile, the Indian government estimates that there is ample stock of medicines to continue until April.

To read more NewsPoints articles, click here.